The expected re-appointment of Margaret Chan as the WHO’s director-general “comes at a perilous moment for WHO,” a Lancet editorial states. Although “WHO is in crisis” and “[r]escue is needed,” the situation is not “a fair reflection of the director-general’s performance,” the editorial adds, noting several successes of her first term, including initiatives on women’s and children’s health and non-communicable diseases (NCDs).

However, “[n]one of this is to say that there have not been disappointments,” the Lancet writes, adding that “[h]er leadership team has not been a success,” and “sometimes one wishes for a sharper message, a stronger articulation of what WHO is for in the 21st century.” The editorial concludes, “These matters can be addressed during a second term. But that term will depend on proper financing of WHO by its donors. And here Dr. Chan faces her greatest test of all” (1/14).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.